Tag Archives: Therapeutic Goods Information (Outcomes of Advertising Complaints Investigations) Specification 2018

TGA’s new complaint system fails the Ease-a-cold test; Outcomes of Advertising Complaints Investigations Specification 2018 enacted

Stimulated by an article in today’s “The Conversation” on Pharmacare Laboratories Ease-a-Cold (below), I decided to try the TGA’s new complaint system.As I mentioned in a comment on this article, this product has been the subject of a previous article … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment